 All-trans retinoic differentiation therapy acute promyelocytic leukemia Clinical results Twenty-two patients acute promyelocytic leukemia all-trans retinoic acid RA day days patients resistant conventional chemotherapy first second third relapse complete response transient responses failure early deaths Length hospitalization number transfusions complete responders Correction coagulation disorders increase WBCs first signs all-trans RA efficacy Morphologic analysis days complete remissions bone marrow BM hypoplasia Presence Auer rods maturing cells differentiation effect treatment remission present patients vitro studies differentiation presence all-trans RA tested cases single nonresponder trans RA vitro vivo Adverse effects RA therapy skin mucosa dryness hypertriglyceridemia increase hepatic transaminases bone pain patients hyperleukocytosis patients Whether maintenance treatment low-dose chemotherapy all-trans RA early relapses patients complete remission CR months study major efficacy all-trans RA patients Remissions differentiation process